Common Contracts
6 similar Agency Agreement contracts by Titan Medical Inc
AGENCY AGREEMENTAgency Agreement • September 7th, 2020 • Ontario
AGENCY AGREEMENTAgency Agreement • June 11th, 2018 • Titan Medical Inc • Ontario
Bloom Burton Securities Inc. (the “Agent”) understands that Titan Medical Inc. (the “Corporation”) proposes to issue and sell a minimum of 33,333,333 units of the Corporation (the “Offered Units”) and up to a maximum of 50,000,000 Offered Units at a price of $0.30 per Offered Unit (the “Offering Price”) for aggregate gross proceeds of a minimum of $10,000,000 (the “Minimum Offering”) up to a maximum of $15,000,000 (the “Maximum Offering”). Each Offered Unit shall consist of (i) one Common Share (as defined herein) (a “Unit Share”) and (ii) one Common Share purchase warrant (a “Warrant”). Each Warrant shall be issued pursuant to and subject to the terms of the Warrant Indenture (as defined herein) Each Warrant shall entitle the holder thereof to purchase one Common Share (a “Warrant Share”) at an exercise price of $0.35 per Warrant Share, subject to adjustment, at any time until 5:00 p.m. (Toronto time) on the date that is five years after the Initial Closing Date (as defined herein).
AGENCY AGREEMENTAgency Agreement • June 11th, 2018 • Titan Medical Inc • Ontario
• Synergist Medical Inc., a predecessor to the Corporation, entered into a patent agreement with Reiza Rayman on May 12, 2008 pursuant to which Synergist Medical Inc. granted to Rayman certain exclusive rights in and to U.S. Patent No. 6,358,196.
AGENCY AGREEMENTAgency Agreement • June 11th, 2018 • Titan Medical Inc • Ontario
Bloom Burton Securities Inc. (the “Agent”) understands that Titan Medical Inc. (the “Corporation”) proposes to issue and sell a minimum of 36,000,000 units of the Corporation (the “Offered Units”) and up to a maximum of 46,000,000 Offered Units at a price of $0.50 per Offered Unit (the “Offering Price”) for aggregate gross proceeds of a minimum of $18,000,000 (the “Minimum Offering”) and a maximum of $23,000,000 (the “Maximum Offering”). Each Offered Unit shall consist of (i) one Common Share (as defined herein) (a “Unit Share”) and (ii) one Common Share purchase warrant (a “Warrant”). Each Warrant shall be issued pursuant to and subject to the terms of the Warrant Indenture (as defined herein) Each Warrant shall entitle the holder thereof to purchase one Common Share (a “Warrant Share”) at an exercise price of $0.60 per Warrant Share, subject to adjustment, at any time until 5:00 p.m. (Toronto time) on the date that is 60 months after the Initial Closing Date (as defined herein). The
AGENCY AGREEMENTAgency Agreement • June 11th, 2018 • Titan Medical Inc • Ontario
• Synergist Medical Inc., a predecessor to the Corporation, entered into a patent agreement with Reiza Rayman on May 12, 2008 pursuant to which Synergist Medical Inc. granted to Rayman certain exclusive rights in and to U.S. Patent No. 6,358,196.
AGENCY AGREEMENTAgency Agreement • January 1st, 2008 • Ontario
